Are calling Jonathan Randall's covers bankruptcy, which he says can sometimes feel a little

monotonous.

Covering bankruptcy can be very boring.

Okay.

Like they're talking about dollars and cents, just like another day at the office, you know,

covering a lot of like these bankruptcy hearings.

But there's one bankruptcy case he's been covering lately that's about a lot more than

just dollars and cents.

It involves the opioid epidemic and one of the companies behind it, Purdue Pharma, members

of the Sackler family own it.

Purdue, facing a mountain of lawsuits over its drug oxycontin, filed for bankruptcy in

2019.

The bankruptcy system was going to resolve all of the liability arising out of the opioid

crisis and specifically lawsuits that have been filed against the Sackler family and those

lawsuits accuse them as the owners of Purdue Pharma and directors of Purdue Pharma of fueling

the opioid crisis.

A few months ago, a bankruptcy judge approved a $4.5 billion settlement, which would have

freed Purdue and the Sackler family from future lawsuits.

But the settlement was appealed and a new judge reviewed the case.

And last week, Jonathan was at home waiting for the ruling to come in.

I am at my apartment, refreshing the court docket every couple of minutes.

And then it was like it's six something.

...